TBC1D7 Antikörper
Kurzübersicht für TBC1D7 Antikörper (ABIN7075849)
Target
Alle TBC1D7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Ratte
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant protein corresponding to Mouse TBC1D7
-
-
-
-
Applikationshinweise
- WB (H,M,R) 1: 500- 1: 1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- TBC1D7 (TBC1 Domain Family, Member 7 (TBC1D7))
-
Andere Bezeichnung
- TBC1D7
-
Hintergrund
- TBC1 domain family member 7 (TBC1D7, TBC7) belongs to a family of TBC (Tre-2/Bub2/Cdc16) containing proteins that function as GTPase-activating proteins (GAPs) . TBC1D7 was initially identified as a novel binding protein within the TSC1-TSC2 complex, where it was thought to associate with TSC1 . Additional research indicates that TBC1D7 is a third subunit of the TSC1-TSC2 complex that possesses Rheb-GAP activity and signals upstream of mTORC1. Knockdown of TBC1D7 limits the association between TSC1 and TSC2, resulting in reduced Rheb-GAP activity and increased mTORC1 signaling . Mutations in the corresponding TBC1D7 gene result in increased mTORC1 signaling, delayed autophagy, and are associated with intellectual disability (ID) and macrocrania.
-
Molekulargewicht
- 36 kDa
-
Gen-ID
- 67046
-
NCBI Accession
- NP_001239568
-
UniProt
- Q9D0K0
Target
-